Karyopharm Therapeutics reported $-43812000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2522M 1123M
Acceleron Pharma XLRN:US $ -70630000 6.97M
Amgen AMGN:US $ 2378M 45M
AstraZeneca AZN:LN -4000000 1.45B
Astrazeneca AZN:US -4000000 1.45B
Avrobio Inc AVRO:US $ -32620000 1.24M
Biocryst Pharmaceuticals BCRX:US $ -44584000 15M
Bristol Myers Squibb BMY:US $ 2985M 18M
Eli Lilly And LLY:US $ 2055.2M 626.8M
Epizyme EPZM:US $ -64140000 5.91M
GlaxoSmithKline GSK:LN 2.67B 712M
Johnson & Johnson JNJ:US $ 7033M 2723M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 5352M 3083M
Mirati Therapeutics MRTX:US $ -79499000 84.69M
Nektar Therapeutics NKTR:US $ -113596000 3.39M
Novartis NVS:US 3.48B 77M
Novartis NOVN:VX 3.48B 77M
Pfizer PFE:US $ 9254M 2592M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Sangamo Biosciences SGMO:US $ -48436000 264K
Takeda 4502:JP 97.43B 151.12B
Tg Therapeutics TGTX:US $ -85128000 7.64M
Ultragenyx Pharmaceutical RARE:US $ -89828000 7.05M
Xencor XNCR:US $ -41300000 50.39M
YTE INCY:US $ 247.47M 92.16M